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Abstract
Neurons communicate at specialized junctions called synapses. Synaptic transmission
occurs when presynaptically released neurotransmitters bind to receptors either continuing
(excitatory) or stopping (inhibitory) the signal in the postsynaptic cell. Excitatory to
inhibitory (E:I) balance is critical for proper neurological function. This balance is achieved
through the function of various proteins such as the ubiquitin ligase, the anaphase
promoting complex (APC). My thesis project focuses on one potential APC substrate, a G
protein-coupled receptor called FSHR-1, and its role in synaptic transmission at the
neuromuscular junction (NMJ) in Caenorhabditis elegans. Previous data from our lab and
others showed that worms lacking fshr-1 have reduced muscle contraction and that FSHR1 expression in neurons is sufficient to restore normal NMJ signaling to these animals. I
hypothesized that fshr-1 acts presynaptically in one or more neuron subclasses to control
NMJ signaling. To identify cells where fshr-1 is expressed, I performed colocalization
experiments with animals expressing green fluorescent protein in fshr-1-expressing cells
and red fluorescent proteins in specific neuron subclasses. Experiments testing fshr-1
expression in sensory neurons in the C. elegans head and tail showed no overlap of red and
green fluorescence, indicating fshr-1 is not expressed in these cells. Similarly,
glutamatergic interneurons, cholinergic motor neurons, and GABAergic motor neurons
also showed no fshr-1 expression. I am currently creating strains to do colocalization with
pharyngeal neurons in the head. I also made a fluorescently tagged FSHR-1 protein to be
used to determine FSHR-1 subcellular localization. This tagged FSHR-1 will be assessed
for co-localization with a red fluorescent protein-labeled synaptic vesicle protein.
Understanding how and where FSHR-1 is acting will allow us to better understand its role
and relation to the APC in E:I balance, which may further our understanding of the
ubiquitin system and E:I imbalances in neurological diseases.
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Chapter 1.
Introduction to the Roles of APC and FSHR-1 in Synaptic Transmission
Everyday new research is being conducted concerning the nervous system and
how it functions. With every bit of information we learn, we are able to begin to
understand how certain neurological diseases work and how we can better treat the
people who are suffering from them. The human brain consists of more than 100 billion
neurons all communicating with each other in a complex network. Chemical signaling is
a key player in this communication, as is electrical signaling. Electrical signaling occurs
when an action potential, an electrical impulse achieved with voltage gated ion channels,
travels down the axon of the neuron and results in the release of neurotransmitters,
chemical signals, into the synapse. The synapse is a specialized junction between a
neuron and another cell. The neurotransmitters travel across the synapse from the
presynaptic (“sending”) neurons to the postsynaptic (“receiving”) cells where they bind
to receptors and elicit a response in the postsynaptic cell that will either continue the
signal (excitatory) or stop it (inhibitory) (Figure 1.1). In excitatory signaling, the
neurotransmitter-receptor combination results in the opening of Na+ and K+ channels in
the postsynaptic cell resulting in a slight depolarization (more positive charges) of the
postsynaptic cell (Sherwood et al. 2004). A combination of many slight depolarizations at
multiple synapses will result in the formation of an action potential and the signal will
continue (Sherwood et al. 2004). In inhibitory signaling, the neurotransmitter-receptor
combination results in increased membrane permeability to K+ or Cl- (Sherwood et al.
2004). This will result in a slight hyperpolarization (more negative charges) of the cell

1

Presynaptic
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Figure 1.1. The basic structure of a synapse. Neurotransmitters, released from the
presynaptic neuron, travel across the synapse and bind to receptors on the postsynaptic
neuron. Image courtesy of J. Kowalski.
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making it less likely for an action potential to form thus stopping the signal from
continuing (Sherwood et al. 2004).
In order for a nervous system to function properly, there must be a balance of
excitatory to inhibitory signaling (E:I balance). This E:I balance is tightly regulated, and
misregulation has been observed in various neurological diseases such as Parkinson’s
(decreased excitation) and epilepsy (increased excitation) (Yi and Ehlers 2005). This
balance is regulated by many different proteins, but the specific functions of many of
these proteins are unknown.

The Ubiquitin Enzyme System
Regulation of processes within cells, including neurons, is a task that is
accomplished in many different ways. One way is by changing the abundance of various
proteins present in the cell. Ubiquitination is one of the ways in which cells can
accomplish this type of regulation (Kowalski and Juo 2012). In this process, polypeptides
called ubiquitin are added in a linked chain onto lysine (Lys) amino acids within a target
protein (the linkages between ubiquitin molecules in the chain also occur between Lys
amino acids) to signal for the protein’s degradation; this often occurs in the proteasome, a
protein complex in the cell which degrades proteins, or the lysosome (Meyer and Rape
2014). The addition of ubiquitin chains with particular linkage types alters the specificity
of the rate of degradation of a target protein, meaning that a cell can essentially control
the abundance of a protein over time based on the type of ubiquitin chain placed on that
protein (Meyer and Rape 2014). In addition to protein degradation, different ubiquitin
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linkage types have been shown to be involved in the coordination of DNA repair,
translation, and trafficking within the cell (Miranda and Sorkin 2007). More specifically,
Lys63 (K63) linked polyubiquitin chains on membrane proteins will signal for trafficking
or repair while a Lys48 (K48) linked polyubiquitin chain will signal for degradation by the
proteasome (Miranda and Sorkin 2007). In addition, Lys11 (K11) linked ubiquitin chains
will signal for a protein’s degradation in the proteasome, resulting in in mitotic exit
(Meyer and Rape 2014).
The addition of ubiquitin to a target protein is accomplished in a three-step
process which involves an activation enzyme (E1), which begins the process of
ubiquitination by using ATP to activate ubiquitin. The E1 then passes the activated
ubiquitin to a conjugating enzyme (E2), which will interact with the ubiquitin ligase (E3)
to add ubiquitin onto the target protein (Hershko and Ciechanover 1998). The human
genome codes for an estimated 500-1000 E3 ligases, which add a variety of linkage
types, but little is known about which ligase enzyme targets which protein (Nakayama
and Nakayama 2006; Akutsu et al. 2016).
In the nervous system, just as in other cells, ubiquitin ligases are integral players
in the regulation of protein activity and abundance. Synaptic vesicle-associated proteins
have been shown to be degraded after ubiquitination in the Drosophila neuromuscular
synapse leading to a decrease in synaptic transmission (Hedge and Upadhya 2007). Also
in Drosophila, flies carrying a mutation in the bendless gene that codes for an E2
ubiquitin conjugating enzyme show defects in neuronal growth and development (Hedge
and Upadhya 2007). Disruption of the ubiquitin system is also observed in the physiology
of neurodegenerative diseases such as Huntington’s and Alzheimer’s (Rubinsztein 2006).
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Understanding the proteins and pathways targeted by specific ubiquitin ligases may help
us to better understand the mechanisms that are dysfunctional in neurological diseases.

C. elegans as a Model Organism in Nervous System Research
In order to study the role of the ubiquitin system in regulating synaptic
transmission, I use the roundworm Caenorhabditis elegans as a model. C. elegans are
excellent model systems for this kind of research because their entire genome has been
sequenced and their neurons have been mapped and labeled (Corsi et al. 2015). They
have a very short generation time, which makes them easy to maintain. Their nervous
system is very simple (302 neurons, 7000 synapses), and it is very similar to humans in
that we share the same neuron types: sensory neurons, interneurons, and motor neurons
(White et al. 1986). Their outer cuticle is translucent, making them an ideal organism for
fluorescent imaging of tagged neuronal proteins. Finally, we can easily create transgenic
strains and perform simple behavioral assays.
To study the regulation of E:I balance in C. elegans, I use a model synapse called
the neuromuscular junction (NMJ). This specialized synapse forms the junction between
presynaptic excitatory cholinergic or inhibitory GABAergic motor neurons that signal to
promote or inhibit the contraction of postsynaptic muscle cells, respectively (Figure 1.2)
(Richmond and Jorgenson 1999). Thus, proper control of postsynaptic muscle contraction
requires strict E:I balance. To measure the outcome of synaptic transmission at the NMJ,
I use a simple paralysis assay involving a drug called aldicarb. Acetylcholinesterase is an
enzyme involved in the hydrolysis of the neurotransmitter acetylcholine. Aldicarb is an
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Figure 1.2. Acetylcholine (ACh) and GABA signaling control muscle contraction
and relaxation, respectively, at the C. elegans NMJ. NMJ function can be measured in
an aldicarb assay. Aldicarb causes a buildup of acetylcholine leading to more cholinergic
signaling and eventual paralysis (Mahoney 2006). Image courtesy of J. Kowalski.
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acetylcholinesterase inhibitor that causes a build-up of acetylcholine at the synapse,
resulting in an increase in cholinergic signaling and eventual paralysis of the worms
(Figure 1.2) (Mahoney 2006). Mutant worms with defects that result in an increase in
synaptic transmission will paralyze much faster than wild-type worms (aldicarb
hypersensitive) due to either increased cholinergic signaling or decreased GABA
signaling; conversely, worms with defects resulting in decreased synaptic transmission
paralyze slower than wild-type worms (aldicarb resistant), due to either decreased
cholinergic signaling or increased GABA signaling (Figure 1.3) (Mahoney 2006). The
aldicarb assay has been used in the identification of a number of genes involved in the
regulation of E:I balance (Sieburth et al 2005; Vashlishan et al. 2008).

7

Figure 1.3. The aldicarb assay measures the rate of paralysis over time of worms
exposed to aldicarb. Wild type worms have no mutations and act as a control in these
experiments. Mutants with increased acetylcholine or decreased GABA transmission
paralyze faster than wild type worms, while those decreased transmission paralyze more
slowly. Image courtesy of J. Kowalski.

8

The Anaphase Promoting Complex is Required for Synaptic Transmission at the C.
elegans Neuromuscular Junction
Using the aldicarb assay, our lab identified one ubiquitin ligase, called the anaphase
promoting complex (APC), that is involved in regulating synaptic transmission at the NMJ
(Kowalski et al. 2014). The APC has multiple subunits, two of which are required for the
recognition of substrates containing either a D-box (RxxLxxxxN/D/E) or KEN-box
(KENxxxN/D/E) recognition motif (Reimann et al. 2001) in their amino acid sequences
(Figure 1.4). The APC tags these proteins with ubiquitin in multiple blocks of branched
K11 chains to allow for better recognition of the target protein for degradation by the
proteasome than with a straight unbranched chain (Meyer and Rape 2014). In the cell, the
APC has been shown to be involved in cell cycle events such as chromosome segregation
in mitosis, cytokinesis, and the initiation of DNA replication (Chang and Barford 2014). It
has also been shown to be functional in neurons, as it is involved in the regulation of
neuronal differentiation and in synaptic transmission at glutamatergic synapses in C.
elegans, Drosophila, and mammalian neurons (Harmey et al. 2009; Juo and Kaplan 2004;
Fu et al. 2011; van Roessel et al. 2004). Our lab has shown that that APC plays a role in
the regulation of E:I balance by promoting GABA release at the NMJ (Kowalski et al.
2014). We showed that APC loss of function mutants are hypersensitive in the aldicarb
assay and that rescuing APC function in only GABAergic motor neurons is sufficient to
restore normal transmission at the neuromuscular junction. We labeled synaptobrevin, a
synaptic vesicle protein, with GFP and observed a build-up of synaptic vesicles in
presynaptic locations in GABAergic motor neurons. This correlated with decreased GABA
release in APC loss of function mutants, indicated by a reduced frequency of spontaneous
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Figure 1.4. The APC is a multi-subunit ubiquitin ligase. The APC recognizes target
proteins using the subunits CDH1 or CDC20 to bind to the D-Box or KEN-box on the
target proteins to which it adds a chain of ubiquitin; this signals for the protein to be
degraded by the proteasome. Image courtesy of J. Kowalski; adapted from Sivakumar and
Gorbsky, 2015.
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inhibitory postsynaptic currents (Kowalski et al. 2014).
Since the APC is an ubiquitin ligase that normally signals for substrate degradation
via the addition of K11-linked ubiquitin chains, the APC must be downregulating the levels
of a specific substrate to regulate E:I balance at the NMJ. To code for a substrate of the
APC at this synapse, a gene must satisfy certain criteria. First, the substrate protein likely
contains a D-box or KEN-box recognition motif and promotes synaptic transmission at the
NMJ since the APC causes substrate degradation and the APC is required to prevent
signaling for excessive muscle excitation at this synapse (Yamano et al. 2004; Kowalski et
al. 2014). Second, worms lacking function of both the APC and its substrate should be
resistant in the aldicarb assay since, without a protein to promote synaptic transmission or
the APC to signal for its degradation, the worms should paralyze much slower than wild
type (Figure 1.5A). Third, substrate levels should increase in APC mutants since the APC
will not be present to tag the substrate for degradation. Fourth and finally, the substrate
should be expressed in the same cells as the APC.

FSHR-1 is a Potential Substrate of the APC at the C. elegans NMJ
The FSHR-1 protein is a G protein-coupled receptor homologous to follicle
stimulating hormone, luteinizing hormone, and thyroid stimulating hormone receptors in
mammals (Cho et al. 2007). In C. elegans, it is required for immune system responses,
germline differentiation, oxidative stress response, cold shock recovery, and has been
hypothesized to be involved in neuropeptide signaling (Powell et al. 2009; Cho et al. 2007;
11
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Synaptic Transmission

B

Figure 1.5. FSHR-1 is a candidate APC substrate at the NMJ. (A) Model for how APC
and FSHR-1 may regulate synaptic transmission if FSHR-1 is an APC substrate. (B) fshr1 mutants suppress the synaptic transmission defects of APC mutants. emb-30 is a subunit
of the APC essential for its function (Furuta et al. 2000). Rates of paralysis over time in
an aldicarb assay. There were three plates per strain (n=3) tested, each containing
approximately 20 worms per plate and 1 mM aldicarb. Averages are shown for each
timepoint along with error bars denoting s.e.m. Assay conducted by E. Damler.
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Sieburth et al. 2005; Miller et al. 2015; Robinson and Powell 2016). FSHR-1 is highly
expressed in the intestine and neurons but not in muscle cells, suggesting a presynaptic
function at the NMJ (Cho et al. 2007).
A screen for genes involved in synaptic transmission performed by Sieburth et al
(2005) identified, among others, fshr-1, and showed fshr-1 loss of function mutants are
resistant in the aldicarb assay. fshr-1 also contains a D-box APC recognition motif.
Accumulation of synaptic vesicles at the NMJ in cholinergic neurons has also been
observed in fshr-1 loss of function mutants indicating a decrease in synaptic transmission
and providing further evidence of its involvement in synaptic transmission (Sieburth et al.
2005). Worms lacking APC and FSHR-1 function have been shown to have the same
aldicarb phenotype as fshr-1 single mutants (resistant) (Figure 1.5B). All of this satisfies
the first two criteria for a protein to be an APC substrate. Nevertheless, the specific
function(s) of this protein in the nervous system, the neuronal subclasses in which it is
expressed, and any direct relationship with the APC have yet to be fully characterized.
Further experiments are still required to determine if the abundance of neuronal FSHR-1is
changing in the absence of APC and in which neurons FSHR-1 is normally active. To
satisfy the remaining criteria to be an APC substrate, fshr-1 must increase in abundance in
APC loss of function mutants and it must be expressed in the same location as the APC
(GABAergic motor neurons) (Kowalski et al. 2014).
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Thesis Statement
Based on our genetic data suggesting that FSHR-1 and the APC may act in the
same pathway to control NMJ transmission and, given the expression of fshr-1 in neurons
and our data suggesting a presynaptic GABAergic motor neuron-specific role for the
APC, I hypothesized that FSHR-1 is a presynaptic APC substrate in GABAergic motor
neurons at the C. elegans NMJ. If this hypothesis is true, then FSHR-1 should be
localized at the synapse in presynaptic GABAergic neurons and should be regulated by
the APC via ubiquitin-induced degradation. In the following chapters I will describe the
experiments I performed to determine the localization of FSHR-1 in neurons in C.
elegans.
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Chapter 2.
Investigation of the Localization of FSHR-1 in C. elegans Neurons

Note of Clarification
The Pfshr-1::gfp transgene was created by Amy Godfrey, and all injections were
performed by J.R. Kowalski. The Peat-4::NLS::mCherry and Pcho-1::NLS::mCherry
strains were obtained from the O. Hobert lab (Columbia University). Some images used
with permission from wormatlas.org (see Appendix A).

Background
The nervous system relies on a balance of excitatory to inhibitory (E:I) signaling
to maintain proper function, and imbalances can be observed in a number of neurological
diseases. Various proteins are utilized to maintain this balance. In order to gain a better
understanding of this E:I balance and how it is regulated, it is important to know the
proteins involved and where they are being expressed. To investigate this, our lab uses
the nematode, Caenorhabditis elegans. Neurons in C. elegans can be split into three
categories: sensory neurons, interneurons, and motor neurons (Fig. 2.1). Some sensory
neurons protrude through the cuticle of the worm into the environment and detect various
stimuli; interneurons connect the sensory neurons to motor neurons, which interact with
muscle cells at a specialized synapse called the neuromuscular junction (NMJ) (White et
al. 1986).
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Figure 2.1. C. elegans nervous system. A general schematic of the three main types of
neurons found in C. elegans. Image courtesy of L. Dreier.
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FSHR-1 is a G-protein coupled receptor that, in C. elegans, can be found in the
intestine and the neurons but not in muscle cells (Cho et al. 2007). Worms lacking fshr-1
function are resistant to aldicarb induced paralysis, suggesting an increase in GABAergic
signaling or a decrease in cholinergic signaling (Sieburth et al. 2005). These data suggest
FSHR-1 acts presynaptically at the neuromuscular junction (NMJ). Previous studies
confirmed fshr-1 is expressed in neurons and controls synaptic vesicle dynamics but did
not identify the specific types of neurons in which it was expressed (Cho et al. 2007;
Sieburth et al. 2005). We have identified FSHR-1 as a candidate substrate of the anaphase
promoting complex (APC), an ubiquitin ligase enzyme. The APC functions in
GABAergic motor neurons where it must be tagging a substrate for degradation by the
proteasome to regulate the release of synaptic vesicles (Kowalski et al. 2014). FSHR-1
may be a substrate of the APC because it contains an APC recognition motif, it was
identified in a screen to be involved in synaptic transmission, and worms lacking fshr-1
function are resistant in the aldicarb assay. To support our hypothesis that FSHR-1 is a
substrate of the APC in controlling NMJ transmission, it must also be expressed in the
same cells as the APC to regulate signaling at this synapse.
Pfshr-1 is the fshr-1 promoter (Cho et al. 2007). A promoter is a short sequence of
DNA containing regulatory information for the gene it precedes to direct when and where
that gene is expressed. For these experiments, instead of promoting the expression of
FSHR-1, Pfshr-1 drove expression of green fluorescent protein (GFP), thus ultimately
causing expression of GFP where fshr-1 is naturally expressed. Worms expressing Pfshr1::gfp were used in colocalization experiments in conjunction with a red fluorescent
marker, mCherry, which marked specific cell types. Previous experiments indicating
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strong expression of Pfshr-1::gfp in the head neurons (Cho et al. 2007) led us to
investigate whether fshr-1 is expressed in glutamatergic neurons as well as in cholinergic
and GABAergic motor neurons at the NMJ. For all of these experiments, if the red and
green fluorescence overlapped, that suggests that FSHR-1 is expressed in the labeled cell
type.

Materials and Methods
Strains used
The following strains were used in colocalization experiments: Pfshr-1::gfp
(JRK35), Pfshr-1::gfp;Peat-4::NLS::mCherry (JRK103), Pfshr-1::gfp;Pcho1::NLS::mCherry (JRK98), Pfshr-1::gfp;Punc-25::mCherry (JRK104). Peat4::NLS::mCherry (OH13645: otIs518(eat-4(fosmid)::SL2::mCherry::H2B + (pBX) pha1(+)] III;pha-1(e2123); him-5(e1490)) and Pcho-1::NLS::mCherry (OH13646,
otIs544(cho-1(fosmid)::SL2::mCherry::H2B + (pBX) pha-1(+)] III;pha-1(e2123); him5(e1490)) were obtained from the lab of Oliver Hobert. All strains were maintained on
NGM agar plates with OP50 E. coli as a food source according to the protocols by
(Brenner 1974).

Subcloning and Strain Generation
To create Punc-25::mCherry, I performed restriction digests using SphI and
BamHI to cut Punc-25 out of a pre-existing plasmid (FJ18) and moved it into a plasmid
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containing mCherry (JRK41). This construct was injected at 100ng/l into the gonad of
the worms where it formed an extrachromosomal array (JRK 105, kjrEx29). To maintain
this strain, I select only worms with red fluorescence.

Crosses
To create Pfshr-1::gfp;Peat-4::NLS::mCherry (for glutamatergic neuron colocalization) and Pfshr-1::gfp;Pcho-1::NLS::mCherry (for cholinergic neuron colocalization), I placed five Pfshr-1::gfp L4 hermaphrodites on a plate with 15 L4 males of
the target mCherry strain (Peat-4::NLS::mCherry or Pcho-1::NLS::mCherry). These
mCherry strains express the him-5 gene which results in a high incidence of males. The
worms were incubated at 25ºC, and the F1 progeny were screened for individuals that
displayed both red and green fluorescence. These individuals were singled (3-5 worms)
and then the progeny of those animals (F2) were screened for 100% red fluorescence
which indicated the integrated mCherry strains had been successfully crossed into the
Pfshr-1::gfp worms. These new strains were maintained by picking green individuals as
the Pfshr-1::gfp is maintained as an extrachromosomal array (JRK98 and JRK103).
To create Pfshr-1::gfp;Punc-25::mCherry (for GABAergic neuron
colocalization), I crossed 5 Punc-25::mCherry hermaphrodites with 15 wild-type males
to create males that were expressing Punc-25::mCherry. I then crossed 5 Pfshr-1::gfp
hermaphrodites with 15 Punc-25::mCherry males. From the F1 progeny, I singled
individual hermaphrodites with red and green fluorescence from which I picked a single
line to be maintained (JRK104).
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DiI colocalization
To perform the 1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine perchlorate
(DiI) labeling experiment, I followed a protocol similar to that of Starich et al. (1995). I
washed a plate of worms in 1.5 mL of M9 buffer and placed them in a microcentrifuge
tube. The tube was spun at 1500 rpm, and then the supernatant was aspirated to leave 100
μL. I then added 1μL of 0.16mg/mL DiI to the tub (giving a final concentration of 1.6
µg/mL) and let it sit in a dark place for two hours, allowing the fluorophore to be taken
up by the worms’ sensory neurons. I plated the entire 100 μL onto an NGM agar plate
with E. coli and allowed the worms to crawl around for one hour to remove excess stain
from the outside of the worms. The worms were then ready to be imaged.

Fluorescent microscopy
All L4 or young adult worms to be imaged were paralyzed with 30 mg/mL 2,3Butanedione 2-monoxime (BDM) and placed on a microscope slide with a 2% agarose in
water pad. Using a Leica DMLB scope fitted with a Exi Aqua cooled CCD camera
(Qimaging) with Metamorph (v7.7) software (Molecular Devices), I imaged the head
neurons at 63X using a gain = 1, 2x2 binning, and exposure times of 300ms for red, 50ms
for green, and auto-expose for brightfield. I took z-stacks over 8m at 0.5m steps of
both red and green and generated a maximum intensity image from the stacks. I merged
the red and green maximum intensity images to look for an overlap of green and red
labeled cell bodies. An overlap would mean fshr-1 is expressed in that specific cell type.
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Results
To determine the neuronal subtype(s) in which fshr-1 is expressed, I performed
colocalization studies using a GFP marker expressed under the promoter for fshr-1 along
with a red fluorescent marker expressed in specific neuronal subclasses. I began these
experiments by looking at the sensory neurons since they are most easily accessible as
they protrude through the cuticle into the environment. I imaged around 40 DiI-labeled
Pfshr-1::gfp expressing worms and saw no overlap of red and green fluorescence,
indicating fshr-1 is not expressed in the sensory neurons in the head (Fig. 2.2 A-D). I did
see a rather characteristic pattern of fshr-1 expressing cells which I then cross referenced
with a map of neurons in the worm (Fig 2.3A) to discover there was a high concentration
of glutamatergic neurons in that area of the worm.
I then imaged the glutamatergic neurons in the head of 20 worms using the strain
Pfshr-1::gfp;Peat-4::NLS::mCherry, but again saw no overlap of red glutamatergic
neurons and green fshr-1 cells, indicating that fshr-1 is also not expressed in those
neurons (Fig. 2.2 E-H). Additional colocalization experiments with 20 worms each of
Pfshr-1::gfp;Pcho-1::NLS::mCherry to examine fshr-1 expression in cholinergic motor
neurons and Pfshr-1::gfp;Punc-25::mCherry to test fshr-1 expression in GABAergic
motor neurons also revealed no overlap of green fshr-1cells and the red neuronal
subtypes, indicating fshr-1 is not expressed in those cells (Fig. 2.2 I-P).
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Figure 2.2. FSHR-1 expression is not found in C. elegans head sensory neurons,
glutamatergic neurons, cholinergic, or GABAergic neurons. (A-D) Representative
worm expressing Pfshr-1::gfp and labeled with 1,1'-dioctadecyl-3,3,3'3'tetramethylindocarbocyanine perchlorate (DiI), a red fluorophore, in the head sensory
neurons. (E-H) Representative worm expressing Pfshr-1::gfp and Peat-4::mcherry
labeling glutamatergic neurons. (I-L) Representative worm expressing Pfshr-1::gfp and
Pcho-1::mcherry labeling cholinergic neurons. (M-P) Representative worm expressing
Pfshr-1::gfp and Punc-25::mcherry labeling GABAergic neurons. All images were taken
at 63x magnification with 2x2 binning and the worms were paralyzed with 30mg/mL 2,3Butanedione 2-monoxime (BDM).
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A

B

Figure 2.3. C. elegans neuron map and pharyngeal neurons. (A) A map of neurons in
the head of adult C. elegans roundworms (Altun et al. 2009). (B) A sample image
showing the localization of some pharyngeal neurons in the head of C. elegans (Altun
and Hall 2009).
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Discussion
The colocalization experiments in this chapter were performed to determine the
specific neuronal subclass(es) in which fshr-1 is expressed. I found no overlap of Pfshr1::gfp and any of the neuronal subtypes I examined (sensory, glutamate, GABA, and
acetylcholine) (Figure 2.2). At this point I have yet to determine the specific cells in
which fshr-1expression is localized. Despite my seemingly conclusive results, there are a
few complications that lead me to want to perform additional experiments to confirm my
expression findings. I would like to repeat all of this imaging using a larger Pfshr-1
promoter. The promoter I used in these experiments was 4kb in length (Cho et al. 2007).
Sieburth et al (2005) performed imaging experiments with a slightly larger (~5kb)
promoter and was able to see some expression in the nerve cord of the worm (although
this was not well documented), which I have not seen with our promoter. In addition, a
larger promoter may result in brighter fluorescence as our promoter seemed dim, and this
may be preventing me from seeing it everywhere it is being expressed. It is possible that
our smaller promoter is lacking some regulatory elements that may result in more
expression in locations we have not yet seen it. Alternatively, Dr. Kowalski is performing
CRISPR (clustered regularly-interspaced short palindromic repeats) experiments to place
GFP directly into the chromosome of the worm where the fshr-1 promoter is located.
CRISPR makes use of artificially designed crRNA to guide a Cas9 protein in the
modification of DNA (Zhao et al. 2014). If she is successful, the new strain will be
expressing GFP under Pfshr-1 with all of the regulatory elements, which should give us
the most accurate picture of endogenous fshr-1 cell type-specific expression.
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In addition to repeating experiments with a larger and/or endogenous promoter,
we plan to begin more colocalization experiments examining the pharyngeal neurons in
C. elegans. Figure 2.3B shows these neurons and how they have a similar pattern to the
characteristic pattern I noticed in my initial sensory neuron imaging. If my hypothesis
that fshr-1 is expressed in pharyngeal neurons is correct, it is possible that worms lacking
FSHR-1 function may show defects in pharyngeal pumping. This is important to assess
because aldicarb-induced paralysis experiments performed by other members of our lab
rely on this pumping for the delivery of aldicarb to the worms. If there is a pumping
defect in fshr-1 mutants, our interpretation of the results of those behavioral assays may
need to be revisited. I plan to perform pharyngeal pumping assays on fshr-1 loss of
function mutants to compare their pumping rate to that of wild type worms to determine
if there is a defect in pharyngeal pumping. Together, these and future experiments will
give us information important for revealing the localization of FSHR-1 as well as the role
it is playing at the neuromuscular junction.
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Chapter 3.
Investigation of the Localization of FSHR-1 within the C. elegans Neuron

Note of Clarification
Amy Godfrey subcloned genomic fshr-1 into pD49.26 to make the JRK 21
plasmid. All injections in this chapter were performed by J.R. Kowalski.

Background
Based on previous research showing the expression of fshr-1 in C. elegans
intestine and neurons but not in muscle, we hypothesize that fshr-1 is acting
presynaptically at the neuromuscular junction (NMJ) to control muscle excitation (Cho et
al. 2007). Additionally, data from our lab showed that fshr-1;emb-30 double mutants
[emb-30 codes for a subunit of the anaphase promoting complex (APC) essential to its
function, mutants of emb-30 lack APC function (Furuta et al. 2000)] have an aldicarb
resistant phenotype similar to that seen with an fshr-1 single mutants (E. Damler,
unpublished data, Figure 1B). This is consistent with the model of APC inhibiting a
substrate, fshr-1, which promotes synaptic transmission (Figure 1.5A). More work
remains to be done to determine if fshr-1 is a direct substrate of the APC at the NMJ;
however, previous work in our lab has shown the rescue of fshr-1 function when it is
expressed in all neurons, as well as only in GABAergic motor neurons in fshr-1 mutants
(Amy Godfrey, unpublished results). Imaging experiments with fshr-1 mutants have also
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shown an accumulation of synaptic vesicles in cholinergic (excitatory) and GABA
(inhibitory) neurons, but this effect is not rescued by fshr-1 re-expression only in
GABAergic neurons (A. Munneke, S. Olofsson, and J. Kolnik, unpublished results).
These data suggest that if fshr-1 is a substrate of the APC to be degraded, it may be
expressed in GABA and/or cholinergic neurons at the NMJ. Kowalski et al. (2014)
showed that the APC is localized to and acts to affect the synapse in GABAergic motor
neurons (and we also have unpublished data that it can localize to presynaptic sites in
cholinergic motor neurons), so we would expect a potential substrate to localize to
presynaptic sites, as well. At this point, no studies have shown subcellular localization of
FSHR-1.
Subcellular colocalization experiments in synapses can be achieved by utilizing
fluorescently tagged synaptic proteins such as the vesicle protein, synaptobrevin, tagged
with green fluorescent protein (GFP). In their study, Kowalski et al. (2014) used a GFP
tagged subunit of the APC, along with synaptobrevin tagged with mCherry, to look for
colocalization of the APC and synaptobrevin as evidence of APC expression at the
synapse.
In order to determine where exactly within neurons fshr-1 is acting (synapse, cell
body, etc.), I needed to first create a GFP tagged version of fshr-1 (Figure 3.1) to place
under cell type specific promoters (depending on results from Chapter 2 and future
experiments). Once FSHR-1::GFP was made, I began work to place it under cell type
specific promoters for GABA and acetylcholine neurons as well as the promoter for fshr1, Pfshr-1. I hypothesize that fshr-1 will be localized to presynaptic sites in GABA and/or
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Figure 3.1. Cartoon model of FSHR-1 with the GFP tag on the cytoplasmic tail and
the D-box region labeled. FSHR-1 is a transmembrane protein crossing the plasma
membrane seven times with the D-box APC recognition motif located upstream of the
GFP tag (image courtesy of D. Godfrey).
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cholinergic motor neurons where it acts to control NMJ signaling downstream of the
APC.
Materials and Methods
Creation of FSHR-1::GFP
To create a GFP tagged version of fshr-1 (Fig. 3.2), I used a plasmid (JRK 21) in
which the genomic fshr-1 sequence (including both exons and introns) had been
subcloned into the vector PD49.26 using the restriction enzymes SacI and SpeI by former
lab member, Amy Godfrey (A. Wasilk, honors thesis). Using QuickChange Site-directed
Mutagenesis, I designed primers specific to fshr-1 that, when used in a simple PCR
reaction, induced an in-frame mutation adding a NotI site to fshr-1 [fshr-1(NotI) JRK46).
The primers used were FSHR-1 FWD(NotI) 5’CCTCCCGAACCATCAAAAAATGCGG
CCGCCCGTCGAAAGTCCACTCCAGCCATA3’ and FSHR-1 REV(NotI) 5’TATGG
CTGGAGTGGACTTTCGACGGGCGGCCGCATTTTTTGATGGTTCGGGAGG3’. I
then performed a restriction digest with NotI followed by gel electrophoresis on fshr1(NotI) and a plasmid containing gfp (FJ28), flanked by NotI restriction sites. This
opened the fshr-1-containing plasmid and isolated gfp from its original plasmid. I then
used calf intestinal phosphatase (CIP) to dephosphorylate the ends of the cut fshr-1
plasmid to ensure it would not ligate back together in the next step. Next, I performed a
ligation reaction at 25ºC using a T4 DNA ligase (New England Biolabs) to insert gfp into
FSHR-1 and transformed this construct in DH5 competent cells on plates with LB agar
medium containing 100g/l ampicillin and allowed colonies to form overnight at 37ºC.
I used the colonies to create liquid LB cultures with 100g/l ampicillin with which I
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Figure 3.2. Schematic of the procedure utilized to create a GFP tagged FSHR-1
protein. Using FSHR-1 FWD(NotI) and FSHR-1 REV(NotI) primers, I performed a PCR
reaction to induce a NotI site insertion in fshr-1. I then digested fshr-1(NotI) and
gfp(NotI) with NotI enzyme to linearize the plasmid and prepare GFP to be ligated into
the fshr-1 sequence.
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performed mini-preps (IBI kit) to isolate the DNA from the bacteria. I sent this DNA to
be sequenced to confirm the presence and orientation of gfp and, once confirmed, created
a stock of this construct in glycerol for future use and named it JRK#50.

Subcloning of FSHR-1::GFP under the Punc-30 promoter for GABAergic neuron
expression
To make Punc-30::fshr-1::gfp, I utilized an In-Fusion subcloning kit from
Clontech. I designed specific primers using fshr-1 and the target plasmid, KP1587 (Punc30) to perform a PCR reaction on fshr-1::gfp from JRK#50 to make homologies on either
side of fshr-1 with KP1587. The primers used were: FSHR-1 FWD 5’ATGGTATTGAT
ATCTGAGCTCAAAAATGACATGCTCAACATATCG ATCGATTC3’ and FSHR-1
REV 5’GGGCCCGTACG GCCGACTAGTACAATAGCTGCTCACAAGGGAAA
CG3’. I was then able to perform restriction digests using SacI and SpeI (New England
Biolabs) on KP1587 to linearize the DNA and then ligated fshr-1::gfp (78ng) into
KP1587 (75ng) under Punc-30 using a 5X In-Fusion enzyme premix. I sent this DNA to
be sequenced to confirm there were no mutations and created a glycerol stock and named
it JRK 68.

Results
FSHR-1::GFP was created (Figure 3.3) and placed under the GABA promoter,
Punc-30.
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Figure 3.3. DNA and amino acid sequence showing portions of fshr-1 flanking gfp.
The black boxed region indicates the portion fshr-1 flanking either side of the unboxed
gfp. Red boxes indicate the two halves of the inserted NotI site.
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Discussion
I successfully made fshr-1::gfp and placed it under the GABA promoter Punc-30.
This construct is now being injected by J.R. Kowalski to create a strain of worms
expressing FSHR-1::GFP in all GABAergic neurons. I can then cross this strain with
another expressing a red fluorescent protein, mCherry, on the synaptic vesicle protein,
synaptobrevin (SNB-1::mCherry), which we have in the lab, expressed in GABAergic
motor neurons. Following that cross, I can do colocalization experiments similar to those
in Chapter 2 to see if FSHR-1 is localized to the synapse or elsewhere in the cell.
I am also continuing to create constructs placing fshr-1::gfp under Punc-17 to
drive expression in cholinergic neurons, as well as under Pfshr-1 with which I can
perform rescue experiments to confirm that the GFP tag on FSHR-1 is not disrupting its
function, as expected based on published work with a similar construct (Cho et al 2007).
In addition to colocalization experiments, I can also perform quantitative imaging
and western blots blotting for GFP to observe changing levels of FSHR-1::GFP in APC
loss of function mutants compared to wild type animals. If the hypothesis that FSHR-1 is
a substrate of the APC is correct, then we should see an increase in expression of FSHR1::GFP in APC loss of function mutants because the APC would not be tagging FSHR-1
for degradation.
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Chapter 4.
Conclusions and Future Directions

In order to understand neurological diseases like Parkinson’s and epilepsy, it is
important to know the proteins and enzymes that interact to affect synaptic transmission.
The goal of this project was to find in which neurons FSHR-1 is expressed and where
within those neurons it localizes using genetic and imaging approaches. FSHR-1 is a Gprotein coupled receptor homologous to follicle stimulating hormone receptor, thyroid
stimulating hormone receptor, and luteinizing hormone receptor in humans and is a
potential neuropeptide receptor in C. elegans, in addition to its functions in germline
differentiation, immune system function, oxidative stress response, and cold shock
recovery (Powell et al. 2009; Cho et al. 2007; Sieburth et al. 2005; Miller et al. 2015;
Robinson and Powell 2016). We hypothesize that, in order to regulate synaptic
transmission, FSHR-1 is tagged for degradation by the ubiquitin ligase, the anaphase
promoting complex (APC). FSHR-1 meets all of the requirements to be a substrate of the
APC at the neuromuscular junction. Worms lacking fshr-1 are resistant in the aldicarb
assay (the opposite phenotype seen with APC loss of function mutants) and the FSHR-1
protein contains a D-box APC recognition motif (Chapter 1). I imaged various neuronal
subtypes expressing red fluorescence along with green fluorescence in fshr-1 expressing
cells to look for colocalization of FSHR-1 and these neuronal subtypes (Chapter 2). I also
continued the work started by Amy Godfrey to make the necessary reagents to tag FSHR1 with GFP for subcellular colocalization experiments (Chapter 3).
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We had evidence that FSHR-1 and the APC act in neurons to regulate synaptic
transmission, but we needed to determine if they function in the same neuron subclass.
Through colocalization experiments I concluded that fshr-1 is not expressed in sensory
neurons, glutamatergic neurons, cholinergic motor neurons, or GABAergic motor
neurons. The fshr-1 promoter we used in these experiments did not show the amount of
expression that has been seen with a slightly larger promoter, so additional experiments
with a larger promoter are required to really rule out fshr-1 expression the
aforementioned neuronal subtypes. In addition, we are preparing to continue our
colocalization experiments by looking for fshr-1 expression in the pharyngeal neurons in
the head of the worms. After seeing a characteristic expression of FSHR-1 in the head of
the worms and finding a similar expression pattern of pharyngeal neurons, I believe this
is a solid direction for this project. If I do indeed find that FSHR-1 is expressed in
pharyngeal neurons, it is possible there may be defects in pharyngeal pumping in worms
lacking FSHR-1, which could explain some of the aldicarb resistance observed with the
animals.
In addition to the colocalization experiments, I successfully created a green
fluorescent protein (GFP)-tagged version of FSHR-1 (FSHR-1::GFP) which I placed
under the Punc-30 promoter to drive expression in GABAergic motor neurons. This
construct is currently being injected into the worms and the new strain will be used for
subcellular colocalization with an mCherry tagged synaptobrevin protein. In addition, I
am making a construct with the Punc-17 promoter, which drives expression in
cholinergic motor neurons; this will also be used for subcellular colocalization. I will also
place FSHR-1::GFP under the promoter for fshr-1 and, once injected, aldicarb assays will
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be performed to confirm the GFP tag is not disrupting the function of FSHR-1 similar to
the methods used by Cho et al. (2007) after the creation of their FSHR-1::GFP.
In the future, experiments will be performed to determine if our prediction that
FSHR-1 is a substrate being tagged for degradation by the APC is correct. Western
blotting and quantitative imaging will be used in conjunction with FSHR-1::GFP to
determine if protein abundance of FSHR-1 changes in the absence of APC. I expect
FSHR-1 abundance to increase (and ubiquitination of FSHR-1 to decrease) in worms
lacking APC function relative to wild type worms. These experiments must be done in
specific neuronal subclasses, so my work to determine in which neurons FSHR-1 is
expressed will be very helpful.
To understand FSHR-1, we need to know in which neurons it is being expressed
and also where within those neurons it is localized; however, that is just a small piece of
the puzzle. To fully understand FSHR-1 we need to know its mechanism of action at the
neuromuscular junction (NMJ). Work is being completed by other members of our lab to
determine a potential signaling pathway FSHR-1 and APC may be involved in to regulate
synaptic transmission. Although the ligand(s) for FSHR-1 are unknown, FSHR-1 has
been hypothesized to be a receptor for neuropeptides (Sieburth et al. 2005). FSHR-1 has
been shown to act upstream of the adenylyl cyclase, ACY-1, and a G-alpha protein,
GSA-1 in germline differentiation (Cho et al. 2007), and protein kinase A (PKA) has
been shown to act downstream of ACY-1 in neuronal pathways controlling release of
synaptic vesicles (Schade et al. 2005). All of our work to investigate these pathways and
the sites of FSHR-1 expression and function will come together to build a model of how
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this protein may be involved regulating the balance of excitatory to inhibitory signaling at
the neuromuscular junction.
If we are to better understand neurological diseases and develop treatments for
those who suffer from them, our work must begin with understanding the neuronal
proteins that regulate the processes that become dysfunctional in these diseases. Many
neuronal proteins are conserved between C. elegans and humans and G protein-coupled
receptors (like FSHR-1) act as drug targets in many treatments being developed today
(Dunworth and Caron 2009). The ubiquitin system is also important in the regulation of
neuronal proteins, so understanding the specific target proteins may also help us to begin
addressing human neurological diseases.
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